Renalytix Plc
Renalytix Plc (RNLX) Stock Overview
Explore Renalytix Plc’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
22.5M
P/E Ratio
-0.56
EPS (TTM)
$-0.62
ROE
1.94%
RNLX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Renalytix Plc (RNLX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.07.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.56 and a market capitalization of 22.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.